RDCA-DAP
News & Events
-
November 2, 2020
C-Path and EATRIS To Collaborate on RDCA-DAP
C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate drug development for rare diseases by increasing the efficiency of translation of potential therapeutics through preclinical and clinical development. C-Path and NORD co-hosted a virtual workshop on October 19, 2020 highlighting the milestones reached and future plans for......